Skip to main content
Clinical Trials/IRCT20230219057459N1
IRCT20230219057459N1
Completed
Phase 3

A comparative study of the effectiveness of injectable Acetaminophen in closing Patent Ductus Arteriosus (PDA) in Term and Preterm Neonates.

Kerman University of Medical Sciences0 sites80 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Kerman University of Medical Sciences
Enrollment
80
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All hospitalized neonates with Patent Ductus Arteriosus(PDA)
  • All term neonates with a gestational age of 37 weeks and more
  • The minimum age is 3 days and the maximum age is 28 days.

Exclusion Criteria

  • Congenital Heart Disease
  • Multiple Congenital Anomalies
  • Life Threatening Disease
  • Lack of parental consent

Outcomes

Primary Outcomes

Not specified

Similar Trials